Cargando…

Transfusion reaction to hyperimmune plasma in patients with severe COVID-19 infection()

Detalles Bibliográficos
Autores principales:	Edroso Jarne, Paloma Eugenia, Lozano Gómez, Herminia, Abansés Moreno, Paula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877211/ https://www.ncbi.nlm.nih.gov/pubmed/33589878 http://dx.doi.org/10.1016/j.medcle.2020.11.011

Ejemplares similares

Reacción transfusional a plasma hiperinmune en pacientes con infección grave por COVID-19
por: Edroso Jarne, Paloma Eugenia, et al.
Publicado: (2021)

Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?
por: Basic-Jukic, Nikolina
Publicado: (2020)

Anti-SARS-CoV-2 hyperimmune plasma workflow
por: Annamaria, Petrungaro, et al.
Publicado: (2020)

Severe anaphylactic reaction in IgA deficient patient following transfusion of whole blood
por: Mukherjee, S., et al.
Publicado: (2011)

Encephalitis as a neurological manifestation of COVID-19()
por: Lozano Gómez, Herminia, et al.
Publicado: (2021)

Encefalitis como manifestación neurológica del COVID-19
por: Lozano Gómez, Herminia, et al.
Publicado: (2021)

The Effect of Sex Discordance on Blood Transfusion Reactions
por: Eini, Mohammad, et al.
Publicado: (2022)

Fulminant myocarditis and cardiogenic shock during SARS-CoV-2 infection()
por: Lozano Gómez, Herminia, et al.
Publicado: (2020)

Response of Severe EV71-Infected Patients to Hyperimmune Plasma Treatment: A Pilot Study
por: Techasaensiri, Chonnamet, et al.
Publicado: (2021)

Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
por: Farag, Youssef M.K.
Publicado: (2020)

Adding up the evidence: Trigger for prophylactic plasma transfusion
por: Raturi, Manish, et al.
Publicado: (2017)

Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
por: Chavda, Vivek P., et al.
Publicado: (2023)

In Reply — Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
por: Joyner, Michael. J., et al.
Publicado: (2020)

Prevalence and trends of transfusion transmitted infections in a regional blood transfusion centre
por: Gupta, Richa, et al.
Publicado: (2011)

Possible Transfusion-Related Acute Lung Injury Following Convalescent Plasma Transfusion in a Patient With Middle East Respiratory Syndrome
por: Chun, Sejong, et al.
Publicado: (2016)

Cochrane corner: convalescent plasma or hyperimmune immunoglobulin for people with COVID-19
por: Nnaji, Chukwudi Arnest, et al.
Publicado: (2020)

Medular ischemia after cardiac arrest()
por: Lozano Gómez, Herminia, et al.
Publicado: (2021)

Comparison of SARS-CoV-2 Hyperimmune Immunoglobulins Following Infection Plus Vaccination vs Infection
por: Bellusci, Lorenza, et al.
Publicado: (2023)

COVID-19convalescent plasma use in the oncology and geriatric patients: Ethical aspects in transfusion medicine
por: Bansal, N., et al.
Publicado: (2022)

Delayed hemolytic transfusion reaction due to anti-D in Rh (D) positive patient
por: Sachan, Deepti, et al.
Publicado: (2016)

Steps taken to alleviate under-reporting of transfusion reactions at a public sector hospital in Pakistan
por: Rashid, Anila, et al.
Publicado: (2016)

An Estimate of Transfusion-Transmitted Infection Prevalence in General Populations
por: Gharehbaghian, Ahmad
Publicado: (2011)

Transfusion transmitted bacterial infection due to a rare organism
por: Sherfudeen, Khaja Mohideen, et al.
Publicado: (2019)

Severe COVID-19 Complicated by Cerebral Venous Thrombosis in a Newborn Successfully Treated with Remdesivir, Glucocorticoids, and Hyperimmune Plasma
por: Cursi, Laura, et al.
Publicado: (2021)

Impact of COVID-19 on blood donation and transfusion services at Lusaka provincial blood transfusion centre, Zambia
por: Kasanga, Maisa, et al.
Publicado: (2020)

Toxoplasma and Blood Transfusion
por: KARIMI, Gharib, et al.
Publicado: (2014)

Black market blood transfusions for Ebola: potential for increases in other infections
por: Folayan, Morenike O., et al.
Publicado: (2014)

COVID-19: Further evidence of no transfusion transmission
por: Luzzi, José Roberto, et al.
Publicado: (2021)

IgA level in plasma as a differential factor for influenza infection in severe viral pneumonia
por: Almansa, Raquel, et al.
Publicado: (2014)

Therapeutic potential of convalescent plasma and hyperimmune immunoglobulins against SARS-CoV-2 BQ.1, BQ.1.1, and XBB variants
por: Bellusci, Lorenza, et al.
Publicado: (2023)

Delayed hemolytic transfusion reaction in children with sickle cell disease: first 5-year retrospective study in mainland France
por: Falguière, Claire, et al.
Publicado: (2022)

Severe anaphylactic reaction to atracurium
por: Gupta, Amrita, et al.
Publicado: (2012)

Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience
por: Cusi, Maria Grazia, et al.
Publicado: (2021)

Hepatitis E Virus Infection after Platelet Transfusion in an Immunocompetent Trauma Patient
por: Loyrion, Emmanuelle, et al.
Publicado: (2017)

To ‘umbrella’ the gonads in transfusion rain
por: Gude, Dilip
Publicado: (2011)

Effects of pentoxifylline on blood transfusion
por: Gökalp, Orhan, et al.
Publicado: (2016)

Elevated Rate of HLA Antibodies in Male COVID-19 Convalescent Plasma Donors: A Risk Factor for Transfusion-Related Acute Lung Injury
por: Juskewitch, Justin E., et al.
Publicado: (2021)

Does multiple transfusion history necessitate additional cross matching evaluation prior to subsequent transfusions?
por: Sheshadri, Veena, et al.
Publicado: (2015)

ANTI-DNA ANTIBODIES IN HYPERIMMUNIZED RABBITS
por: Christian, Charles L., et al.
Publicado: (1965)

Hyperimmune Globulins for the Management of Infectious Diseases
por: Pati, Ilaria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cli82c9i25lfh6l4iiktaksadi